Germany agrees deal with CureVac, GSK for mRNA vaccines until 2029
The five-year contract allows for production of up to 80 million doses at short notice until 2029, CureVac said, adding that those…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.